Protalix(DE:PBDA)
€2.510.00 (0.00%)
DE:PBDA
Protalix financials statements
€2.51
At close:0.00 (0.00%)
Protalix (PBDA) Ratios
1 Followers
Protalix Ratios
DE:PBDA's free cash flow for Q3 2026 was $3.17M. For the 2026 fiscal year, DE:PBDA's free cash flow was decreased by $-737.00K and operating cash flow was $3.90M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.51 | 2.34 | 1.54 | 1.38 | 1.86 |
| Quick Ratio | 1.54 | 1.52 | 1.12 | 0.87 | 1.32 |
| Cash Ratio | 0.55 | 0.77 | 0.52 | 0.53 | 1.18 |
| Solvency Ratio | -0.15 | 0.14 | 0.19 | -0.21 | -0.33 |
| Operating Cash Flow Ratio | -0.45 | 0.34 | -0.03 | -0.77 | -0.31 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -0.06 | 0.00 | 0.00 |
| Net Current Asset Value | $ 32.56M | $ 29.87M | $ 19.07M | $ -21.55M | $ -18.04M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.08 | 0.33 | 0.60 | 0.45 |
| Debt-to-Equity Ratio | 0.17 | 0.13 | 0.82 | -3.15 | -5.55 |
| Debt-to-Capital Ratio | 0.15 | 0.11 | 0.45 | 1.47 | 1.22 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 1.61 | 1.28 |
| Financial Leverage Ratio | 1.71 | 1.70 | 2.52 | -5.24 | -12.20 |
| Debt Service Coverage Ratio | -3.31 | 4.99 | 0.51 | -4.47 | -2.52 |
| Interest Coverage Ratio | -4.62 | 3.69 | 3.29 | -5.15 | -2.72 |
| Debt to Market Cap | 0.00 | 0.00 | 0.18 | 0.42 | 0.76 |
| Interest Debt Per Share | 0.12 | 0.09 | 0.46 | 0.74 | 0.93 |
| Net Debt to EBITDA | 2.15 | -2.18 | 0.31 | -1.52 | 0.29 |
| Profitability Margins | |||||
| Gross Profit Margin | 47.85% | 54.46% | 64.91% | 58.87% | 57.37% |
| EBIT Margin | -8.37% | 9.77% | 17.93% | -24.91% | -52.31% |
| EBITDA Margin | -5.60% | 12.21% | 19.75% | -22.63% | -49.40% |
| Operating Profit Margin | -10.43% | 7.34% | 15.97% | -27.32% | -53.36% |
| Pretax Profit Margin | -10.63% | 7.78% | 13.08% | -30.22% | -71.92% |
| Net Profit Margin | -12.52% | 5.49% | 12.69% | -31.33% | -71.92% |
| Continuous Operations Profit Margin | -12.52% | 5.49% | 12.69% | -31.33% | -71.92% |
| Net Income Per EBT | 117.76% | 70.58% | 97.03% | 103.68% | 100.00% |
| EBT Per EBIT | 101.96% | 106.05% | 81.89% | 110.63% | 134.80% |
| Return on Assets (ROA) | -8.02% | 3.99% | 9.84% | -26.76% | -37.44% |
| Return on Equity (ROE) | -13.69% | 6.79% | 24.76% | 140.29% | 456.96% |
| Return on Capital Employed (ROCE) | -9.85% | 8.20% | 26.89% | -55.72% | -50.54% |
| Return on Invested Capital (ROIC) | -9.61% | 5.61% | 16.38% | -53.17% | -49.07% |
| Return on Tangible Assets | -8.02% | 3.99% | 9.84% | -26.76% | -37.44% |
| Earnings Yield | -4.67% | 2.15% | 6.92% | -22.48% | -75.13% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.97 | 18.36 | 12.42 | 10.39 | 11.14 |
| Payables Turnover | 5.23 | 5.36 | 5.32 | 3.34 | 2.34 |
| Inventory Turnover | 1.07 | 1.14 | 1.21 | 1.17 | 0.91 |
| Fixed Asset Turnover | 4.19 | 5.33 | 6.02 | 4.94 | 3.87 |
| Asset Turnover | 0.64 | 0.73 | 0.78 | 0.85 | 0.52 |
| Working Capital Turnover Ratio | 1.41 | 1.81 | 3.55 | 2.33 | -33.92 |
| Cash Conversion Cycle | 332.79 | 270.68 | 263.24 | 238.99 | 277.63 |
| Days of Sales Outstanding | 61.17 | 19.88 | 29.38 | 35.14 | 32.76 |
| Days of Inventory Outstanding | 341.39 | 318.83 | 302.47 | 313.06 | 400.83 |
| Days of Payables Outstanding | 69.78 | 68.04 | 68.61 | 109.21 | 155.97 |
| Operating Cycle | 402.57 | 338.72 | 331.85 | 348.20 | 433.59 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.15 | 0.12 | -0.02 | -0.52 | -0.23 |
| Free Cash Flow Per Share | -0.17 | 0.10 | -0.04 | -0.53 | -0.27 |
| Dividend Paid and CapEx Coverage Ratio | -7.32 | 6.77 | -1.15 | -39.81 | -7.05 |
| Capital Expenditure Coverage Ratio | -7.32 | 6.77 | -1.15 | -39.81 | -7.05 |
| Operating Cash Flow Coverage Ratio | -1.44 | 1.57 | -0.05 | -0.75 | -0.31 |
| Operating Cash Flow to Sales Ratio | -0.23 | 0.16 | -0.02 | -0.52 | -0.27 |
| Free Cash Flow Yield | -9.64% | 5.42% | -2.05% | -38.59% | -31.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -21.40 | 46.53 | 14.46 | -4.45 | -1.33 |
| Price-to-Sales (P/S) Ratio | 2.68 | 2.55 | 1.83 | 1.39 | 0.96 |
| Price-to-Book (P/B) Ratio | 2.93 | 3.16 | 3.58 | -6.24 | -6.08 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -10.37 | 18.45 | -48.71 | -2.59 | -3.13 |
| Price-to-Operating Cash Flow Ratio | -11.79 | 15.72 | -91.18 | -2.66 | -3.57 |
| Price-to-Earnings Growth (PEG) Ratio | 0.07 | -0.70 | -0.10 | 0.09 | -0.01 |
| Enterprise Value Multiple | -45.74 | 18.73 | 9.60 | -7.68 | -1.65 |
| Enterprise Value | 135.02M | 122.12M | 124.23M | 82.77M | 31.20M |
| EV to EBITDA | -45.74 | 18.73 | 9.60 | -7.68 | -1.65 |
| EV to Sales | 2.56 | 2.29 | 1.90 | 1.74 | 0.81 |
| EV to Free Cash Flow | -9.91 | 16.52 | -50.36 | -3.23 | -2.66 |
| EV to Operating Cash Flow | -11.26 | 14.08 | -94.26 | -3.31 | -3.03 |
| Tangible Book Value Per Share | 0.61 | 0.60 | 0.50 | -0.22 | -0.14 |
| Shareholders’ Equity Per Share | 0.61 | 0.60 | 0.50 | -0.22 | -0.14 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.18 | 0.29 | 0.03 | -0.04 | 0.00 |
| Revenue Per Share | 0.67 | 0.74 | 0.97 | 0.98 | 0.87 |
| Net Income Per Share | -0.08 | 0.04 | 0.12 | -0.31 | -0.62 |
| Tax Burden | 1.18 | 0.71 | 0.97 | 1.04 | 1.00 |
| Interest Burden | 1.27 | 0.80 | 0.73 | 1.21 | 1.37 |
| Research & Development to Revenue | 0.36 | 0.24 | 0.26 | 0.62 | 0.78 |
| SG&A to Revenue | 0.22 | 0.23 | 0.00 | -0.29 | -0.10 |
| Stock-Based Compensation to Revenue | 0.04 | 0.06 | 0.05 | 0.04 | 0.06 |
| Income Quality | 1.82 | 2.96 | -0.16 | 1.67 | 0.37 |
Currency in USD
